Chronic Kidney Disease: Underlying Molecular Mechanisms

Chronic kidney disease (CKD) is a worldwide public health problem that must be addressed. The global increase in CKD prevalence is associated with an increase in conventional disease risk factors (e.g., diabetes and hypertension), which may be exacerbated by additional variables such as environmenta...

Full description

Saved in:
Bibliographic Details
Other Authors: Carvalho, Márcia (Editor), Belo, Luís (Editor)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_113881
005 20230911
003 oapen
006 m o d
007 cr|mn|---annan
008 20230911s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-8540-6 
020 |a 9783036585413 
020 |a 9783036585406 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-8540-6  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MMG  |2 bicssc 
100 1 |a Carvalho, Márcia  |4 edt 
700 1 |a Belo, Luís  |4 edt 
700 1 |a Carvalho, Márcia  |4 oth 
700 1 |a Belo, Luís  |4 oth 
245 1 0 |a Chronic Kidney Disease: Underlying Molecular Mechanisms 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (216 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Chronic kidney disease (CKD) is a worldwide public health problem that must be addressed. The global increase in CKD prevalence is associated with an increase in conventional disease risk factors (e.g., diabetes and hypertension), which may be exacerbated by additional variables such as environmental and occupational exposure to toxic compounds. Authors contributed to this Special Issue by highlighting the finding of potential novel biomarkers of the disease and more effective therapy alternatives, as well as works that enhance the understanding of CKD pathogenesis and its related complications. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Pharmacology  |2 bicssc 
653 |a kidney 
653 |a lymphatics 
653 |a sodium 
653 |a NKCC1 transporter 
653 |a CKD 
653 |a inflammation 
653 |a TNF-alpha 
653 |a TNFR 
653 |a biomarkers 
653 |a chronic kidney disease 
653 |a hypertension 
653 |a children 
653 |a short-chain fatty acids 
653 |a developmental origins of health and disease (DOHaD) 
653 |a gut microbiota 
653 |a probiotics 
653 |a prebiotics 
653 |a trimethylamine-N-oxide 
653 |a oxidative stress 
653 |a uremic toxins 
653 |a TRPC6 
653 |a UUO 
653 |a NZO mice 
653 |a fibrosis 
653 |a SH045 
653 |a heavy metals 
653 |a cadmium 
653 |a mercury 
653 |a arsenic 
653 |a cellular injury 
653 |a urine proteome 
653 |a FSGS 
653 |a MCD 
653 |a podocyte dysfunction 
653 |a mass spectrometry 
653 |a growth hormone 
653 |a cachexia 
653 |a lipolysis 
653 |a adipose tissue browning 
653 |a muscle mass 
653 |a muscle function 
653 |a skeletal muscle wasting 
653 |a reactive oxygen species (ROS) 
653 |a exercise 
653 |a Marinobufagenin (MBG) 
653 |a end-stage renal disease (ESRD) 
653 |a nervous and immune systems 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/7722  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/113881  |7 0  |z DOAB: description of the publication